
The 2024 guideline from the Royal Australian College of General Practitioners and Healthy Bones Australia offers updated, evidence-based recommendations for osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age. This third edition supersedes the 2017 guideline, incorporating new research, expert consensus, and advancements in pharmacological therapies.
This guideline provides recommendations for the use of fracture risk assessment tools, particularly FRAX, for risk stratification, addresses the risk of rebound vertebral fracture following denosumab cessation, discusses removal of strontium as a therapy, clarifies “imminent” or “very high” fracture risk in patients and highlights the importance of calcium and vitamin D status, and the early use of osteoanabolic therapies.
The main recommendations are the following:
© 2026 Global Fragility Fracture Network | All Rights Reserved I Designed by Aaron Knight